CLSI M33-A

Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE

Clinical and Laboratory Standards Institute, 02/01/2004

Publisher: CLSI

File Format: PDF

$120.00$240.30

Description

Published:01/02/2004

Pages:39

This document provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus.

More CLSI standard pdf

CLSI GP34-A (R2018)

Tubes and Additives for Venous and Capillary Blood Specimen Collection; Approved Guideline, GP34A

$90.00 $180.00

CLSI POCT08-A (R2018)

Quality Practices in Noninstrumented Near-Patient Testing: An Instructional Manual and Resources for Health Care Workers; Approved Guideline, POCT08AE

$90.00 $180.00

CLSI MM06-A2 (R2018)

Quantitative Molecular Methods for Infectious Diseases; Approved Guideline, MM06A2E

$90.00 $180.00

CLSI POCT07-A (R2018)

Quality Management: Approaches to Reducing Errors at the Point of Care; Approved Guideline, POCT07AE

$90.00 $180.00